{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:15:33Z","timestamp":1772165733695,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This work was supported by the Natural Science Foundation of Anhui Medical University","award":["2021xkj094"],"award-info":[{"award-number":["2021xkj094"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"DOI":"10.1186\/s12884-025-08065-2","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T11:12:30Z","timestamp":1759230750000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expression and clinical significance of miR-377-3p and cyclin G2 in preeclampsia patients"],"prefix":"10.1186","volume":"25","author":[{"given":"Sanqiang","family":"Niu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangjun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"5","key":"8065_CR1","doi-asserted-by":"publisher","first-page":"e218401","DOI":"10.1001\/jamanetworkopen.2021.8401","volume":"4","author":"Y Yang","year":"2021","unstructured":"Yang Y, Le Ray I, Zhu J, Zhang J, Hua J, Reilly M. Preeclampsia prevalence, risk factors, and pregnancy outcomes in Sweden and China. JAMA Netw Open. 2021;4(5):e218401.","journal-title":"JAMA Netw Open"},{"issue":"2S","key":"8065_CR2","doi-asserted-by":"publisher","first-page":"S973","DOI":"10.1016\/j.ajog.2020.10.025","volume":"226","author":"BA Bakrania","year":"2022","unstructured":"Bakrania BA, George EM, Granger JP. Animal models of preeclampsia: investigating pathophysiology and therapeutic targets. Am J Obstet Gynecol. 2022;226(2S):S973\u201387.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"8065_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s40292-020-00425-7","volume":"28","author":"E Chourdakis","year":"2021","unstructured":"Chourdakis E, Oikonomou N, Fouzas S, Hahalis G, Karatza AA. Preeclampsia emerging as a risk factor of cardiovascular disease in women. High Blood Press Cardiovasc Prev. 2021;28(2):103\u201314.","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"5","key":"8065_CR4","doi-asserted-by":"publisher","first-page":"553.e1","DOI":"10.1016\/j.ajog.2023.05.015","volume":"229","author":"S Zhou","year":"2023","unstructured":"Zhou S, Li J, Yang W, Xue P, Yin Y, Wang Y, et al. Noninvasive preeclampsia prediction using plasma cell-free RNA signatures. Am J Obstet Gynecol. 2023;229(5):553.e1-553.e16.","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"8065_CR5","doi-asserted-by":"publisher","first-page":"e1446","DOI":"10.1002\/ctm2.1446","volume":"13","author":"H Mirzakhani","year":"2023","unstructured":"Mirzakhani H, Handy DE, Lu Z, Oppenheimer B, Litonjua AA, Loscalzo J, et al. Integration of circulating microRNAs and transcriptome signatures identifies early-pregnancy biomarkers of preeclampsia. Clin Transl Med. 2023;13(11):e1446.","journal-title":"Clin Transl Med"},{"issue":"6","key":"8065_CR6","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3892\/etm.2022.11659","volume":"24","author":"Z Li","year":"2022","unstructured":"Li Z, Wang J, Li D, Chen H, Meng T. miR-372-3p promotes preeclampsia progression by regulating twist1. Exp Ther Med. 2022;24(6):723.","journal-title":"Exp Ther Med"},{"issue":"18","key":"8065_CR7","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1080\/15384101.2022.2075644","volume":"21","author":"H Liu","year":"2022","unstructured":"Liu H, Wang X. Mir-200b-3p is upregulated in the placental tissues from patients with preeclampsia and promotes the development of preeclampsia via targeting profilin 2. Cell Cycle. 2022;21(18):1945\u201357.","journal-title":"Cell Cycle"},{"issue":"1","key":"8065_CR8","doi-asserted-by":"publisher","first-page":"2219774","DOI":"10.1080\/10641955.2023.2219774","volume":"42","author":"S Su","year":"2023","unstructured":"Su S, Zhong L, Huang S, Deng L, Pang L. MiRNA-494 induces trophoblast senescence by targeting SIRT1. Hypertens Pregnancy. 2023;42(1):2219774.","journal-title":"Hypertens Pregnancy"},{"issue":"6","key":"8065_CR9","first-page":"4655","volume":"19","author":"S Hu","year":"2019","unstructured":"Hu S, Li J, Tong M, et al. MicroRNA-144-3p may participate in the pathogenesis of preeclampsia by targeting Cox-2. Mol Med Rep. 2019;19(6):4655\u201362.","journal-title":"Mol Med Rep"},{"key":"8065_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.placenta.2023.10.004","volume":"143","author":"B Sun","year":"2023","unstructured":"Sun B, Jiang T, Yong J, Peng J, Dong S, Gu Y, et al. Mir-135b-5p targets ADAM12 to suppress invasion and accelerate trophoblast apoptosis in preeclampsia. Placenta. 2023;143:69\u201379.","journal-title":"Placenta"},{"issue":"6","key":"8065_CR11","doi-asserted-by":"publisher","first-page":"661.e1","DOI":"10.1016\/j.ajog.2008.12.045","volume":"200","author":"XM Zhu","year":"2009","unstructured":"Zhu XM, Han T, Sargent IL, Yin GW, Yao YQ. Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies. Am J Obstet Gynecol. 2009;200(6):661.e1-661.e6617.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"8065_CR12","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1007\/s13277-013-1440-5","volume":"35","author":"GG Sun","year":"2014","unstructured":"Sun GG, Zhang J, Hu WN. CCNG2 expression is downregulated in colorectal carcinoma and its clinical significance. Tumour Biol. 2014;35(4):3339\u201346.","journal-title":"Tumour Biol"},{"issue":"10","key":"8065_CR13","doi-asserted-by":"publisher","first-page":"6165","DOI":"10.7314\/APJCP.2013.14.10.6165","volume":"14","author":"WJ Li","year":"2013","unstructured":"Li WJ, Liu GL, Yu F, Xiang XX, Lu YF, Xiao HZ, et al. CCNG2 suppressor biological effects on thyroid cancer cell through promotion of CDK2 degradation. Asian Pac J Cancer Prev. 2013;14(10):6165\u201371.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"8065_CR14","doi-asserted-by":"publisher","first-page":"e21169","DOI":"10.1096\/fj.202001559RR","volume":"35","author":"M Sun","year":"2021","unstructured":"Sun M, Gao J, Meng T, Liu S, Chen H, Liu Q, et al. Cyclin G2 upregulation impairs migration, invasion, and network formation through RNF123\/Dvl2\/JNK signaling in the trophoblast cell line HTR8\/SVneo, a possible role in preeclampsia. FASEB J. 2021;35(2):e21169.","journal-title":"FASEB J"},{"issue":"23","key":"8065_CR15","first-page":"10332","volume":"23","author":"WJ Qin","year":"2019","unstructured":"Qin WJ, Wang WP, Wang XB, Zhang XT, Du JD. Mir-1290 targets CCNG2 to promote the metastasis of oral squamous cell carcinoma. Eur Rev Med Pharmacol Sci. 2019;23(23):10332\u201342.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"8065_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1177\/1933719110374115","volume":"18","author":"K Mayor-Lynn","year":"2011","unstructured":"Mayor-Lynn K, Toloubeydokhti T, Cruz AC, Chegini N. Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor. Reprod Sci. 2011;18(1):46\u201356.","journal-title":"Reprod Sci"},{"issue":"4","key":"8065_CR17","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/AOG.0000000000005532","volume":"143","author":"RM Burwick","year":"2024","unstructured":"Burwick RM, Rodriguez MH. Angiogenic biomarkers in preeclampsia. Obstet Gynecol. 2024;143(4):515\u201323.","journal-title":"Obstet Gynecol"},{"key":"8065_CR18","doi-asserted-by":"publisher","first-page":"782845","DOI":"10.3389\/fbioe.2021.782845","volume":"9","author":"A Cirkovic","year":"2021","unstructured":"Cirkovic A, Stanisavljevic D, Milin-Lazovic J, Rajovic N, Pavlovic V, Milicevic O, et al. Preeclamptic women have disrupted placental microRNA expression at the time of preeclampsia diagnosis: meta-analysis. Front Bioeng Biotechnol. 2021;9:782845.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"8065_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12916-022-02495-x","volume":"20","author":"S Bao","year":"2022","unstructured":"Bao S, Zhou T, Yan C, Bao J, Yang F, Chao S, et al. A blood-based miRNA signature for early non-invasive diagnosis of preeclampsia. BMC Med. 2022;20(1):303.","journal-title":"BMC Med"},{"issue":"5","key":"8065_CR20","doi-asserted-by":"publisher","first-page":"4530","DOI":"10.1002\/jcp.29330","volume":"235","author":"Y Yuan","year":"2020","unstructured":"Yuan Y, Wang X, Sun Q, Dai X, Cai Y. Microrna-16 is involved in the pathogenesis of pre-eclampsia via regulation of Notch2. J Cell Physiol. 2020;235(5):4530\u201344.","journal-title":"J Cell Physiol"},{"issue":"1","key":"8065_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12943-022-01595-9","volume":"21","author":"J Hua","year":"2022","unstructured":"Hua J, Wang X, Ma L, Li J, Cao G, Zhang S, et al. Circvapa promotes small cell lung cancer progression by modulating the miR-377-3p and miR-494-3p\/IGF1R\/AKT axis. Mol Cancer. 2022;21(1):123.","journal-title":"Mol Cancer"},{"key":"8065_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.biopha.2015.01.012","volume":"70","author":"R Wang","year":"2015","unstructured":"Wang R, Ma Y, Yu D, Zhao J, Ma P. miR-377 functions as a tumor suppressor in human clear cell renal cell carcinoma by targeting ETS1. Biomed Pharmacother. 2015;70:64\u201371.","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"8065_CR23","doi-asserted-by":"publisher","first-page":"14813","DOI":"10.1007\/s13277-016-5295-4","volume":"37","author":"W Chang","year":"2016","unstructured":"Chang W, Liu M, Xu J, Fu H, Zhou B, Yuan T, et al. Mir-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3. Tumour Biol. 2016;37(11):14813\u201324.","journal-title":"Tumour Biol"},{"issue":"21","key":"8065_CR24","first-page":"4494","volume":"20","author":"J Zhang","year":"2016","unstructured":"Zhang J, Zhao M, Xue ZQ, Liu Y, Wang YX. MiR-377 inhibited tumorous behaviors of non-small cell lung cancer through directly targeting CDK6. Eur Rev Med Pharmacol Sci. 2016;20(21):4494\u20139.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"8065_CR25","doi-asserted-by":"publisher","first-page":"BSR20193425","DOI":"10.1042\/BSR20193425","volume":"40","author":"H Wang","year":"2020","unstructured":"Wang H, Wei Z, Li H, et al. MiR-377-3p inhibits atherosclerosis-associated vascular smooth muscle cell proliferation and migration via targeting neuropilin2. Biosci Rep. 2020;40(6):BSR20193425.","journal-title":"Biosci Rep"},{"key":"8065_CR26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.preghy.2018.02.001","volume":"12","author":"E Weiner","year":"2018","unstructured":"Weiner E, Feldstein O, Tamayev L, Grinstein E, Barber E, Bar J, Schreiber L, et al. Placental histopathological lesions in correlation with neonatal outcome in preeclampsia with and without severe features. Pregnancy Hypertens. 2018;12:6\u201310.","journal-title":"Pregnancy Hypertens"},{"issue":"3","key":"8065_CR27","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1007\/s13277-013-1346-2","volume":"35","author":"GG Sun","year":"2014","unstructured":"Sun GG, Hu WN, Cui DW, Zhang J. Decreased expression of CCNG2 is significantly linked to the malignant transformation of gastric carcinoma. Tumour Biol. 2014;35(3):2631\u20139.","journal-title":"Tumour Biol"},{"issue":"4","key":"8065_CR28","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1007\/s13277-013-1442-3","volume":"35","author":"JQ Chen","year":"2014","unstructured":"Chen JQ, Liu CJ, Wen HX, Shi CL, Zhang HS, Li M, Sun GG. Changes in the expression of cyclin G2 in esophageal cancer cell and its significance. Tumour Biol. 2014;35(4):3355\u201362.","journal-title":"Tumour Biol"},{"issue":"4","key":"8065_CR29","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1007\/s13277-013-1389-4","volume":"35","author":"DW Cui","year":"2014","unstructured":"Cui DW, Cheng YJ, Jing SW, Sun GG. Effect of cyclin G2 on proliferative ability of prostate cancer PC-3 cell. Tumour Biol. 2014;35(4):3017\u201324.","journal-title":"Tumour Biol"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-08065-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-08065-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-08065-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T11:12:31Z","timestamp":1759230751000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-025-08065-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8065"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-08065-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4392334\/v1","asserted-by":"object"}]},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"9 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiments were authorized by the academic ethics committee of Bozhou Clinical College of Anhui Medical University. All procedures were strictly implemented by the code of ethics. All the subjects involved were fully informed of the objective of the study and signed informed consent before sampling. The study was in accordance with the relevant guidelines and regulation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"957"}}